Related Experiment Video
Updated: Feb 1, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Splicing Factor SF3B4 Suppresses Pancreatic Cancer Growth and Migration by Inhibiting Autophagy
So-Hyun Choi1,2,3, Jiyoon Seo1,2,3, Seung Min Jeong4,2,3
1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Background/Aim:
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, characterized by aggressive progression, profound chemoresistance and unique metabolic adaptations such as elevated autophagy. Although the splicing factor SF3B4 has been reported to function as an oncogene in other malignancies, its role in PDAC remains unclear. This study aimed to elucidate the functional and mechanistic significance of SF3B4 in PDAC.
Materials And Methods:
SF3B4 expression in PDAC was analyzed using patient datasets and experimental models. Functional assays including cell proliferation, colony formation, migration, and autophagy analyses were performed in PDAC cells. Reactive oxygen species (ROS) levels were evaluated. Sensitivity to 5-fluorouracil (5-FU) and apoptotic responses were also evaluated.
Results:
SF3B4 acts as a tumor suppressor in PDAC by inhibiting autophagy, a process that this cancer uniquely depends on for survival. SF3B4 overexpression inhibited proliferation, colony formation and migration of PDAC cells. Mechanistically, SF3B4 suppressed autophagic flux, resulting in increased ROS accumulation and subsequent inhibition of tumorigenic phenotypes. Treatment with the antioxidant N-acetylcysteine (NAC) rescued the tumor suppressive effects of SF3B4 overexpression. Moreover, SF3B4 overexpression sensitized PDAC cells to 5-FU, accompanied by enhanced apoptotic responses.
Conclusion:
SF3B4 is a context-dependent splicing factor that functions as a tumor suppressor in PDAC by regulating autophagy and redox homeostasis. Targeting the SF3B4-autophagy-ROS axis may represent a promising strategy to suppress PDAC progression and overcome chemoresistance.
Insights
SF3B4 acts as a tumor suppressor in pancreatic cancer by inhibiting autophagy and increasing reactive oxygen species (ROS). This finding offers a new strategy to combat pancreatic ductal adenocarcinoma (PDAC) and chemoresistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with known chemoresistance and metabolic adaptations like increased autophagy.
- The splicing factor SF3B4's role in PDAC is not well understood, despite its oncogenic function in other cancers.
Purpose of the Study:
- To investigate the functional and mechanistic role of SF3B4 in pancreatic ductal adenocarcinoma (PDAC).
Main Methods:
- SF3B4 expression analysis in PDAC patient datasets and experimental models.
- Functional assays assessing cell proliferation, colony formation, migration, and autophagy in PDAC cells.
- Evaluation of reactive oxygen species (ROS) levels, 5-fluorouracil (5-FU) sensitivity, and apoptotic responses.
Main Results:
- SF3B4 functions as a tumor suppressor in PDAC by inhibiting autophagy, a critical survival pathway for this cancer.
- SF3B4 overexpression reduced PDAC cell proliferation, colony formation, and migration.
- SF3B4 suppressed autophagic flux, leading to increased ROS, which inhibited tumor phenotypes. This effect was reversed by N-acetylcysteine (NAC).
- SF3B4 overexpression enhanced PDAC cell sensitivity to 5-FU and increased apoptosis.
Conclusions:
- SF3B4 acts as a context-dependent tumor suppressor in PDAC by modulating autophagy and redox homeostasis.
- The SF3B4-autophagy-ROS pathway presents a potential therapeutic target for suppressing PDAC progression and overcoming chemoresistance.
More Related Videos
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancer Cell Migration through Invadopodia
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature